Funded Tech Companies
Gladius Pharmaceuticals
Headquartered in Montreal QC, Gladius Pharmaceuticals has funding from GlaxoSmithKline, Lumira Capital and Fonds de solidarite FTQ.
Company Overview
Company Name
Gladius Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3575 Avenue du Parc 4310
Montreal QC, H2X 3P9
Canada
Montreal QC, H2X 3P9
Canada
Phone
Website
Email Address
Company Background Information
Overview
Gladius Pharmaceuticals Inc. is a Montréal-based biotechnology firm developing novel drugs to treat life-threatening, multi-drug-resistant bacterial infections. Gladius is a disruptive platform technology play, capable of developing multiple novel drug candidates.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/24/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Paul Truex
Chief Scientific Officer
Larry Sutton
VP - Finance
Lynda Choquette
Company Investors
- GlaxoSmithKline
- Lumira Capital (Daniel Hétu)
- Fonds de solidarite FTQ
Browse more funded tech companies:
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs